Clinical Trial Update: Study to Evaluate CORT125134 in Participants With Cushing's Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial update for CORT125134 in participants with Cushing's syndrome; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Syndrome

Drugs mentioned

• CORT125134

Snippet

Sponsor: Corcept Therapeutics | Conditions: Cushing's Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2019-09-25